Home
Market
Screener
Supply Chains
Search Company
Help
Learn

Home
Market
Screener
Supply Chains
Search Company
Help
Learn

More on Inspire Medical Systems, Inc.

Valuation & fair value
Financial statements
Earnings (pre / post)
PEG ratio
PE ratio vs industry
Supply-chain map
Peer benchmarks
Options positioning
Institutional holders (13F)

Compare with peers

AKTX · Akari Therapeutics Plc
LLY · ELI LILLY & Co
BMYMP · Bristol-Myers Squibb Company PFD CONV 2
JNJ · JOHNSON & JOHNSON
ONC · BeOne Medicines Ltd.
ABBV · AbbVie Inc.

Explore

All stocks A–Z
Stocks by sector
Head-to-head comparisons
Browse 500+ stocks
Free DCF calculator
Stock screener
Supply-chain maps
Research & analysis

Stocks A–Z·Sectors·Developers·Pricing·Compare data APIs·30 years of statements in ChatGPT/Claude·DCF guide·DCF calculator·Market

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.

Stock Lists

Growth Analysis - INSP

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth13.60%

5Y CAGR51.21%

10Y CAGR60.56%

Net Income

1Y Growth171.77%

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y Growth175.00%

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y Growth41.21%

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y Growth22.71%

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-1.59%

5Y CAGR73.41%

10Y CAGR60.19%

Equity

1Y Growth13.26%

5Y CAGR27.73%

10Y CAGRN/A

Cash Flow

1Y Growth-10.19%

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	13.6%	20.8%	30.8%	51.2%	60.6%	N/A	N/A	N/A
FY 2024 Dec 31, 2024	28.5%	40.3%	51.0%	57.8%	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	53.2%	63.6%	75.6%	65.3%	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	74.7%	88.0%	70.7%	70.2%	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	102.3%	68.7%	66.5%	70.0%	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	40.6%	51.0%	59.3%	70.5%	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	62.2%	69.5%	70.9%	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	77.1%	75.5%	84.8%	N/A	N/A	N/A	N/A	N/A
FY 2017 Dec 31, 2017	73.9%	88.8%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2016 Dec 31, 2016	105.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2015 Dec 31, 2015	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

More on Inspire Medical Systems, Inc.

Valuation & fair value
Financial statements
Earnings (pre / post)
PEG ratio
PE ratio vs industry
Supply-chain map
Peer benchmarks
Options positioning
Institutional holders (13F)

Compare with peers

AKTX · Akari Therapeutics Plc
LLY · ELI LILLY & Co
BMYMP · Bristol-Myers Squibb Company PFD CONV 2
JNJ · JOHNSON & JOHNSON
ONC · BeOne Medicines Ltd.
ABBV · AbbVie Inc.

Explore

All stocks A–Z
Stocks by sector
Head-to-head comparisons
Browse 500+ stocks
Free DCF calculator
Stock screener
Supply-chain maps
Research & analysis

Stocks A–Z·Sectors·Developers·Pricing·Compare data APIs·30 years of statements in ChatGPT/Claude·DCF guide·DCF calculator·Market

Growth Analysis - INSP

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth13.60%

5Y CAGR51.21%

10Y CAGR60.56%

Net Income

1Y Growth171.77%

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y Growth175.00%

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y Growth41.21%

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y Growth22.71%

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-1.59%

5Y CAGR73.41%

10Y CAGR60.19%

Equity

1Y Growth13.26%

5Y CAGR27.73%

10Y CAGRN/A

Cash Flow

1Y Growth-10.19%

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	13.6%	20.8%	30.8%	51.2%	60.6%	N/A	N/A	N/A
FY 2024 Dec 31, 2024	28.5%	40.3%	51.0%	57.8%	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	53.2%	63.6%	75.6%	65.3%	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	74.7%	88.0%	70.7%	70.2%	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	102.3%	68.7%	66.5%	70.0%	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	40.6%	51.0%	59.3%	70.5%	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	62.2%	69.5%	70.9%	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	77.1%	75.5%	84.8%	N/A	N/A	N/A	N/A	N/A
FY 2017 Dec 31, 2017	73.9%	88.8%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2016 Dec 31, 2016	105.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2015 Dec 31, 2015	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A